ABC Arbitrage SA Makes New Investment in Immutep Limited (NASDAQ:IMMP)

ABC Arbitrage SA acquired a new position in Immutep Limited (NASDAQ:IMMP) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 69,897 shares of the biotechnology company’s stock, valued at approximately $152,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Meridian Wealth Management LLC raised its position in shares of Immutep by 4.5% during the third quarter. Meridian Wealth Management LLC now owns 398,450 shares of the biotechnology company’s stock worth $881,000 after acquiring an additional 17,250 shares during the last quarter. Fortitude Advisory Group L.L.C. bought a new stake in shares of Immutep during the fourth quarter worth $28,000. Finally, XY Capital Ltd raised its position in shares of Immutep by 52.0% during the fourth quarter. XY Capital Ltd now owns 164,655 shares of the biotechnology company’s stock worth $357,000 after acquiring an additional 56,306 shares during the last quarter. Institutional investors and hedge funds own 2.32% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Robert W. Baird boosted their target price on Immutep from $6.00 to $7.00 and gave the stock an “outperform” rating in a research report on Friday, November 15th.

Immutep Trading Up 0.5 %

NASDAQ IMMP opened at $1.96 on Friday. The stock has a 50-day simple moving average of $2.04 and a 200 day simple moving average of $2.09. The company has a current ratio of 18.25, a quick ratio of 18.25 and a debt-to-equity ratio of 0.01. Immutep Limited has a 12 month low of $1.66 and a 12 month high of $3.34.

Immutep Company Profile

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.